|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
2 Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA
* To whom correspondence should be addressed. E-mail: htsukamo{at}usc.edu.
Diminished activity of peroxisome proliferator-activated receptor
(PPAR
) is implicated in
activation of hepatic stellate cells (HSC), a critical event in development of liver fibrosis. In the
present study, we investigated PPAR
regulation by tumor necrosis factor
(TNF
) in a HSC
cell line designated as BSC. In BSC, TNF
decreased both basal and ligand (GW1929)-induced
PPAR
mRNA levels without changing its protein expression. Nuclear extracts from BSC treated
with TNF
showed decreased binding of PPAR
to PPAR-responsive element (PPRE) as
determined by electrophoretic mobility shift assay. In BSC transiently transfected with a
PPAR
1 expression vector and a PPRE-luciferase reporter gene, TNF
decreased both basal and
GW1929-induced transactivation of the PPRE promoter. TNF
increased activation of
extracellular signal-regulated kinases (ERK) 1/2 and c-Jun NH2-Terminal Kinase (JNK),
previously implicated in phosphorylation of Ser82 of PPAR
1 and resultant negative regulation of
PPAR
transactivity. In fact, TNF
failed to inhibit transactivity of a Ser82 Ala PPAR
1 mutant
in BSC. TNF
-mediated inhibition of PPAR
transactivity was not blocked with a
Ser32 Ala/Ser36 Ala mutant of inhibitory NF
B
(I
B
). These results suggest that TNF
inhibits
PPAR
transactivity in cultured HSC at least in part by diminished PPAR
-PPRE (DNA) binding
and ERK1/2-mediated phosphorylation of Ser82 of PPAR
1, but not via the NF
B pathway.
This article has been cited by other articles:
![]() |
A. H. Remels, H. R. Gosker, P. Schrauwen, R. C. Langen, and A. M. Schols Peroxisome proliferator-activated receptors: a therapeutic target in COPD? Eur. Respir. J., March 1, 2008; 31(3): 502 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Cheng, H. She, Y.-P. Han, J. Wang, S. Xiong, K. Asahina, and H. Tsukamoto Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G39 - G49. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |